Skip to content
2000
image of Venlafaxine and Delirium: Understanding the Association

Abstract

Delirium represents a significant clinical, economic, and societal challenge, frequently arising in hospitalized patients due to multiple factors, including pharmacological triggers. Recognizing and preventing delirium is crucial to improving patient outcomes and reducing healthcare costs. This review focuses on the association between venlafaxine, a commonly used antidepressant, and delirium. We explore potential mechanisms, clinical presentations, and risk factors linked to venlafaxine-induced delirium, emphasizing the need for heightened awareness among clinicians. The findings underscore the importance of vigilance during drug initiation, dosage adjustment, or withdrawal to mitigate the risk of this neuropsychiatric condition.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X378277250702051515
2025-07-15
2025-09-13

  • From This Site

    /content/journals/cn/10.2174/011570159X378277250702051515
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ormseth C.H. LaHue S.C. Oldham M.A. Josephson S.A. Whitaker E. Douglas V.C. Predisposing and precipitating factors associated With delirium. JAMA Netw. Open 2023 6 1 e2249950 10.1001/jamanetworkopen.2022.49950 36607634
    [Google Scholar]
  2. Aldecoa C. Bettelli G. Bilotta F. Sanders R.D. Aceto P. Audisio R. Cherubini A. Cunningham C. Dabrowski W. Forookhi A. Gitti N. Immonen K. Kehlet H. Koch S. Kotfis K. Latronico N. MacLullich A.M.J. Mevorach L. Mueller A. Neuner B. Piva S. Radtke F. Blaser A.R. Renzi S. Romagnoli S. Schubert M. Slooter A.J.C. Tommasino C. Vasiljewa L. Weiss B. Yuerek F. Spies C.D. Update of the European Society of anaesthesiology and intensive care medicine evidence-based and consensus-based guideline on postoperative delirium in adult patients. Eur. J. Anaesthesiol. 2023 41 2 81 108 10.1097/EJA.0000000000001876 37599617
    [Google Scholar]
  3. Mattison M.L.P. Delirium. Ann. Intern. Med. 2020 173 7 ITC49 ITC64 10.7326/AITC202010060 33017552
    [Google Scholar]
  4. Schenning K.J. Mahanna-Gabrielli E. Deiner S.G. Update on perioperative delirium. Anesthesiol. Clin. 2023 41 3 567 581 10.1016/j.anclin.2023.02.007 37516495
    [Google Scholar]
  5. Kington J. Jenkinson J. Delirium: Who cares? Acta Psychiatr. Scand. 2023 147 5 398 400 10.1111/acps.13469 36468297
    [Google Scholar]
  6. Matsuura Y. Ohno Y. Toyoshima M. Ueno T. Effects of non‐pharmacologic prevention on delirium in critically ill patients: A network meta‐analysis. Nurs. Crit. Care 2023 28 5 727 737 10.1111/nicc.12780 35624556
    [Google Scholar]
  7. Yan E. Veitch M. Saripella A. Alhamdah Y. Butris N. Tang-Wai D.F. Tartaglia M.C. Nagappa M. Englesakis M. He D. Chung F. Association between postoperative delirium and adverse outcomes in older surgical patients: A systematic review and meta-analysis. J. Clin. Anesth. 2023 90 111221 10 10.1016/j.jclinane.2023.111221 37515876
    [Google Scholar]
  8. Keenan C.R. Jain S. Delirium. Med. Clin. North Am. 2022 106 3 459 469 10.1016/j.mcna.2021.12.003 35491066
    [Google Scholar]
  9. Alexander S.K. Needham E. Diagnosis of delirium: A practical approach. Pract. Neurol. 2023 23 3 192 199 10.1136/pn‑2022‑003373 36581459
    [Google Scholar]
  10. Sadeghirad B. Dodsworth B.T. Schmutz Gelsomino N. Goettel N. Spence J. Buchan T.A. Crandon H.N. Baneshi M.R. Pol R.A. Brattinga B. Park U.J. Terashima M. Banning L.B.D. Van Leeuwen B.L. Neerland B.E. Chuan A. Martinez F.T. Van Vugt J.L.A. Rampersaud Y.R. Hatakeyama S. Di Stasio E. Milisen K. Van Grootven B. van der Laan L. Thomson Mangnall L. Goodlin S.J. Lungeanu D. Denhaerynck K. Dhakharia V. Sampson E.L. Zywiel M.G. Falco L. Nguyen A.L.V. Moss S.J. Krewulak K.D. Jaworska N. Plotnikoff K. Kotteduwa-Jayawarden S. Sandarage R. Busse J.W. Mbuagbaw L. Perioperative Factors associated with postoperative delirium in patients undergoing noncardiac surgery. JAMA Netw. Open 2023 6 10 e2337239 10.1001/jamanetworkopen.2023.37239 37819663
    [Google Scholar]
  11. Oh E.S. Fong T.G. Hshieh T.T. Inouye S.K. Delirium in older persons. JAMA 2017 318 12 1161 1174 10.1001/jama.2017.12067 28973626
    [Google Scholar]
  12. Oldham M.A. Spira A.P. Yurcheshen M. Pigeon W.R. Palanca B.J.A. Lee H.B. Novel applications of sleep pharmacology as delirium therapeutics. Sleep Med. Rev. 2025 79 102016 10.1016/j.smrv.2024.102016 39541802
    [Google Scholar]
  13. Swarbrick C.J. Partridge J.S.L. Evidence‐based strategies to reduce the incidence of postoperative delirium: A narrative review. Anaesthesia 2022 77 1 92 101 10.1111/anae.15607 35001376
    [Google Scholar]
  14. Egberts A. Moreno-Gonzalez R. Alan H. Ziere G. Mattace-Raso F.U.S. Anticholinergic drug burden and delirium: A systematic review. J. Am. Med. Dir. Assoc. 2021 22 1 65 73.e4 10.1016/j.jamda.2020.04.019 32703688
    [Google Scholar]
  15. Hoel R.W. Giddings Connolly R.M. Takahashi P.Y. Polypharmacy management in older patients. Mayo Clin. Proc. 2021 96 1 242 256 10.1016/j.mayocp.2020.06.012 33413822
    [Google Scholar]
  16. Wang E. Belley-Côté E.P. Young J. He H. Saud H. D’Aragon F. Um K. Alhazzani W. Piticaru J. Hedden M. Whitlock R. Mazer C.D. Kashani H.H. Zhang S.Y. Lucas A. Timmerman N. Nishi C. Jain D. Kugler A. Beaver C. Kloppenburg S. Schulman S. Borges F.K. Kavosh M. Wada C. Lin S. Sibilio S. Lauw M. Benz A. Szczeklik W. Mokhtari A. Jacobsohn E. Spence J. Effect of perioperative benzodiazepine use on intraoperative awareness and postoperative delirium: A systematic review and meta-analysis of randomised controlled trials and observational studies. Br. J. Anaesth. 2023 131 2 302 313 10.1016/j.bja.2022.12.001 36621439
    [Google Scholar]
  17. Fischer M.A. Corsetti M. Geriatric psychiatric emergencies. Emerg. Med. Clin. North Am. 2024 42 1 135 149 10.1016/j.emc.2023.06.016 37977746
    [Google Scholar]
  18. Maldonado J.R. Neuropathogenesis of delirium: Review of current etiologic theories and common pathways. Am. J. Geriatr. Psychiatry 2013 21 12 1190 1222 10.1016/j.jagp.2013.09.005 24206937
    [Google Scholar]
  19. Brailowsky S. García O. Ethanol, GABA and epilepsy. Arch. Med. Res. 1999 30 1 3 9 10.1016/S0188‑0128(98)00013‑X 10071417
    [Google Scholar]
  20. Inouye S.K. Westendorp R.G.J. Saczynski J.S. Delirium in elderly people. Lancet 2014 383 9920 911 922 10.1016/S0140‑6736(13)60688‑1 23992774
    [Google Scholar]
  21. Hshieh T.T. Inouye S.K. Oh E.S. Delirium in the elderly. Clin. Geriatr. Med. 2020 36 2 183 199 10.1016/j.cger.2019.11.001 32222295
    [Google Scholar]
  22. Bugiani O. Delirium and dementia in the elderly: Sometimes associated or always together? Eur. Neurol. 2023 86 3 161 165 10.1159/000530226 36958295
    [Google Scholar]
  23. Sakusic A. Rabinstein A.A. ICU Delirium. Neurol. Clin. 2025 43 1 1 13 10.1016/j.ncl.2024.07.001 39547734
    [Google Scholar]
  24. Alizadeh Otaghvar H. Farzan R. Tamimi P. Ghaderi A. Najafi M. Tohidian M. Izadi F. Mazhari S.A. Prevalence of delirium and its related factors in burn patients: A systematic review and meta-analysis. Arch. Acad. Emerg. Med. 2023 12 1 e7 10.22037/aaem.v12i1.2136 38162381
    [Google Scholar]
  25. Neufeld K.J. Yue J. Robinson T.N. Inouye S.K. Needham D.M. Antipsychotic Medication for prevention and treatment of delirium in hospitalized adults: A systematic review and meta‐analysis. J. Am. Geriatr. Soc. 2016 64 4 705 714 10.1111/jgs.14076 27004732
    [Google Scholar]
  26. Kaye A.D. Dufrene K. Cooley J. Walker M. Shah S. Hollander A. Shekoohi S. Robinson C.L. Neuropsychiatric effects associated with opioid-based management for palliative care patients. Curr. Pain Headache Rep. 2024 28 7 587 594 10.1007/s11916‑024‑01248‑0 38564124
    [Google Scholar]
  27. Lee J.H. Suzuki J. N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review. Gen. Hosp. Psychiatry 2024 91 60 65 10.1016/j.genhosppsych.2024.09.005 39278010
    [Google Scholar]
  28. Vyklicky V Korinek M Smejkalova T Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 2014 63 1 S191 S203 10.33549/physiolres.932678
    [Google Scholar]
  29. Mony L. Paoletti P. Mechanisms of NMDA receptor regulation. Curr. Opin. Neurobiol. 2023 83 102815 10 10.1016/j.conb.2023.102815 37988826
    [Google Scholar]
  30. Geoffroy C. Paoletti P. Mony L. Positive allosteric modulation of NMDA receptors: Mechanisms, physiological impact and therapeutic potential. J. Physiol. 2022 600 2 233 259 10.1113/JP280875 34339523
    [Google Scholar]
  31. Korkatti-Puoskari N. Tiihonen M. Caballero-Mora M.A. Topinkova E. Szczerbińska K. Hartikainen S. on the Behalf of the EuGMS Task & Finish group on FRIDs Therapeutic dilemma’s: Antipsychotics use for neuropsychiatric symptoms of dementia, delirium and insomnia and risk of falling in older adults, a clinical review. Eur. Geriatr. Med. 2023 14 4 709 720 10.1007/s41999‑023‑00837‑3 37495836
    [Google Scholar]
  32. Faeder M. Hale E. Hedayati D. Israel A. Moschenross D. Peterson M. Peterson R. Piechowicz M. Punzi J. Gopalan P. Preventing and treating delirium in clinical settings for older adults. Ther. Adv. Psychopharmacol. 2023 13 20451253231198462 10.1177/20451253231198462 37701890
    [Google Scholar]
  33. Iglseder B. Frühwald T. Jagsch C. Delirium in geriatric patients. Wien. Med. Wochenschr. 2022 172 5-6 114 121 10.1007/s10354‑021‑00904‑z 35006521
    [Google Scholar]
  34. Springer B. Hyperactive delirium with severe agitation. Emerg. Med. Clin. North Am. 2024 42 1 41 52 10.1016/j.emc.2023.06.011 37977752
    [Google Scholar]
  35. Wiedemann A. Stein J. Manseck A. Kirschner-Hermanns R. Bannowsky A. Wirz S. Kuru T.H. Salem J. Polypharmacy and medication review in the context of prehabilitation. Urologie 2023 62 10 1025 1033 10.1007/s00120‑023‑02174‑6 37682348
    [Google Scholar]
  36. Glaser I Polypharmacy and Delirium in the Elderly. Praxis (Bern) 2023 112 335 339 10.1024/1661‑8157/a003998
    [Google Scholar]
  37. Jaqua E.E. Nguyen V.T.N. Chin E. Delirium in older persons: Prevention, evaluation, and management. Am. Fam. Physician 2023 108 3 278 287 37725462
    [Google Scholar]
  38. Kurisu K. Miyabe D. Furukawa Y. Shibayama O. Yoshiuchi K. Association between polypharmacy and the persistence of delirium: A retrospective cohort study. Biopsychosoc. Med. 2020 14 1 25 10.1186/s13030‑020‑00199‑3 33042216
    [Google Scholar]
  39. Heinrich M. Nottbrock A. Borchers F. Mörgeli R. Kruppa J. Winterer G. Slooter A.J.C. Spies C. BioCog Consortium Preoperative medication use and development of postoperative delirium and cognitive dysfunction. Clin. Transl. Sci. 2021 14 5 1830 1840 10.1111/cts.13031 33934508
    [Google Scholar]
  40. Safdar M. Colosimo C. Khurshid M.H. Spencer A.L. Hejazi O. Castanon L. Hosseinpour H. Magnotti L.J. Bhogadi S.K. Joseph B. Drugs, delirium, and trauma: Substance use and incidence of delirium after traumatic brain injury. J. Surg. Res. 2024 301 45 53 10.1016/j.jss.2024.05.042 38909477
    [Google Scholar]
  41. Liu J. Wang T. Song J. Cao L. Effect of esketamine on postoperative analgesia and postoperative delirium in elderly patients undergoing gastrointestinal surgery. BMC Anesthesiology 2024 24 1
    [Google Scholar]
  42. Poulin T.G. Jaworska N. Stelfox H.T. Fiest K.M. Moss S.J. Clinical practice guideline recommendations for diagnosis and management of anxiety and depression in hospitalized adults with delirium: A systematic review. Syst. Rev. 2023 12 1 174 10.1186/s13643‑023‑02339‑6 37749654
    [Google Scholar]
  43. Lu Y. Yin G. Jin C. Gu K. Bao D. Xu W. Yang Z. The application value of esketamine and dexmedetomidine in preventing postoperative delirium and hyperalgesia in elderly patients with thoracic anesthesia. Altern. Ther. Health Med. 2024 30 3 80 85 37917895
    [Google Scholar]
  44. Minoc E.M. Villain C. Benbrika S. Chrétien B. Descatoire P. Heraudeau M. Sassier M. Pierre M. Martinaud O. Dolladille C. Lelong-Boulouard V. Association between antidepressant use and delirium in older adults: An analysis of the World Health Organization’s global pharmacovigilance database. BMC Geriatr. 2024 24 1 600 610 10.1186/s12877‑024‑05022‑0 38997635
    [Google Scholar]
  45. Wang L.Y. Wang X.P. Lv J.M. Shan Y.D. Jia S.Y. Yu Z.F. Miao H.T. Xin Y. Zhang D.X. Zhang L.M. NLRP3–GABA signaling pathway contributes to the pathogenesis of impulsive-like behaviors and cognitive deficits in aged mice. J. Neuroinflammation 2023 20 1 162 10 10.1186/s12974‑023‑02845‑3 37434240
    [Google Scholar]
  46. Zaki M.E.A. AL-Hussain S.A. Al-Mutairi A.A. Samad A. Masand V.H. Ingle R.G. Rathod V.D. Gaikwad N.M. Rashid S. Khatale P.N. Burakale P.V. Jawarkar R.D. Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro’s revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder. PLoS One 2024 19 1 e0286848 10.1371/journal.pone.0286848 38227609
    [Google Scholar]
  47. Sadlonova M. Duque L. Smith D. Madva E.N. Amonoo H.L. Vogelsang J. Staton S.C. von Arnim C.A.F. Huffman J.C. Celano C.M. Pharmacologic treatment of delirium symptoms: A systematic review. Gen. Hosp. Psychiatry 2022 79 60 75 10.1016/j.genhosppsych.2022.10.010 36375344
    [Google Scholar]
  48. Lin C.J. Su I.C. Huang S.W. Chen P.Y. Traynor V. Chang H.C.R. Liu I.H. Lai Y.S. Lee H.C. Rolls K. Chiu H.Y. Delirium assessment tools among hospitalized older adults: A systematic review and metaanalysis of diagnostic accuracy. Ageing Res. Rev. 2023 90 102025 10.1016/j.arr.2023.102025 37527704
    [Google Scholar]
  49. Vadagandla K. Sridhar Reddy P. Antony S. Prasanthy Reddy P. A Case of Refractory Delirium Managed by a Multimodal Approach Using Atypical Antipsychotics, Antidepressants, and Benzodiazepines in an ICU Setting. Cureus 2022 14 3 e23354 10.7759/cureus.23354 35475066
    [Google Scholar]
  50. Ju J.W. Nam K. Sohn J.Y. Joo S. Lee J. Lee S. Cho Y.J. Jeon Y. Association between intraoperative body temperature and postoperative delirium: A retrospective observational study. J. Clin. Anesth. 2023 87 111107 111110 10.1016/j.jclinane.2023.111107 36924749
    [Google Scholar]
  51. Sidoli C. Zambon A. Tassistro E. Rossi E. Mossello E. Inzitari M. Cherubini A. Marengoni A. Morandi A. Bellelli G. Tarasconi A. Sella M. Paternò G. Faggian G. Lucarelli C. De Grazia N. Alberto C. Porcella L. Nardiello I. Chimenti E. Zeni M. Romairone E. Minaglia C. Ceccotti C. Guerra G. Mantovani G. Monacelli F. Minaglia C. Candiani T. Santolini F. Minaglia C. Rosso M. Bono V. Sibilla S. Dal Santo P. Ceci M. Barone P. Schirinzi T. Formenti A. Nastasi G. Isaia G. Gonella D. Battuello A. Casson S. Calvani D. Boni F. Ciaccio A. Rosa R. Sanna G. Manfredini S. Cortese L. Rizzo M. Prestano R. Greco A. Lauriola M. Gelosa G. Piras V. Arena M. Cosenza D. Bellomo A. LaMontagna M. Gabbani L. Lambertucci L. Perego S. Parati G. Basile G. Gallina V. Pilone G. Giudice C. Pietrogrande L. Mosca M. Corazzin I. Rossi P. Nunziata V. D’Amico F. Grippa A. Giardini S. Barucci R. Cossu A. Fiorin L. Arena M. Distefano M. Lunardelli M. Brunori M. Ruffini I. Abraham E. Varutti A. Fabbro E. Catalano A. Martino G. Leotta D. Marchet A. Dell’Aquila G. Scrimieri A. Davoli M. Casella M. Cartei A. Polidori G. Basile G. Brischetto D. Motta S. Saponara R. Perrone P. Russo G. Del D. Car C. Pirina T. Franzoni S. Cotroneo A. Ghiggia F. Volpi G. Menichetti C. Bo M. Panico A. Calogero P. Corvalli G. Mauri M. Lupia E. Manfredini R. Fabbian F. March A. Pedrotti M. Veronesi M. Strocchi E. Borghi C. Bianchetti A. Crucitti A. DiFrancesco V. Fontana G. Geriatria A. Bonanni L. Barbone F. Serrati C. Ballardini G. Simoncelli M. Ceschia G. Scarpa C. Brugiolo R. Fusco S. Ciarambino T. Biagini C. Tonon E. Porta M. Venuti D. DelSette M. Poeta M. Barbagallo G. Trovato G. Delitala A. Arosio P. Reggiani F. Zuliani G. Ortolani B. Mussio E. Girardi A. Coin A. Ruotolo G. Castagna A. Masina M. Cimino R. Pinciaroli A. Tripodi G. Cassadonte F. Vatrano M. Scaglione L. Fogliacco P. Muzzuilini C. Romano F. Padovani A. Rozzini L. Cagnin A. Fragiacomo F. Desideri G. Liberatore E. Bruni A. Orsitto G. Franco M. Bonfrate L. Bonetto M. Pizio N. Magnani G. Cecchetti G. Longo A. Bubba V. Marinan L. Cotelli M. Turla M. Brunori M. Sessa M. Abruzzi L. Castoldi G. LoVetere D. Musacchio C. Novello M. Cavarape A. Bini A. Leonardi A. Seneci F. Grimaldi W. Seneci F. Fimognari F. Bambar V. Saitta A. Corica F. Braga M. Servi Ettorre E. Camellini Bellelli C.G. Annoni G. Marengoni A. Bruni A. Crescenzo A. Noro G. Turco R. Ponzetto M. Giuseppe L. Mazzei B. Maiuri G. Costaggiu D. Damato R. Fabbro E. Formilan M. Patrizia G. Santuar L. Gallucci M. Minaglia C. Paragona M. Bini P. Modica D. Abati C. Clerici M. Barbera I. NigroImperiale F. Manni A. Votino C. Castiglioni C. Di M. Degl’Innocenti M. Moscatelli G. Guerini S. Casini C. Dini D. DeNotariis S. Bonometti F. Paolillo C. Riccardi A. Tiozzo A. SamySalamaFahmy A. Riccardi A. Paolillo C. DiBari M. Vanni S. Scarpa A. Zara D. Ranieri P. Alessandro M. Calogero P. Corvalli G. Di F. Pezzoni D. Platto C. D’Ambrosio V. Ivaldi C. Milia P. DeSalvo F. Solaro C. Strazzacappa M. Bo M. Panico A. Cazzadori M. Bonetto M. Grasso M. Troisi E. Magnani G. Cecchetti G. Guerini V. Bernardini B. Corsini C. Boffelli S. Filippi A. Delpin K. Faraci B. Bertoletti E. Vannucci M. Crippa P. Malighetti A. Caltagirone C. DiSant S. Bettini D. Maltese F. Formilan M. Abruzzese G. Minaglia C. Cosimo D. Azzini M. Cazzadori M. Colombo M. Procino G. Fascendini S. Barocco F. Del P. D’Amico F. Grippa A. Mazzone A. Cottino M. Vezzadini G. Avanzi S. Brambilla C. Orini S. Sgrilli F. Mello A. Lombardi Muti L.E. Dijk B. Fenu S. Pes C. Gareri P. Castagna A. Passamonte M. Rigo R. Locusta L. Caser L. Rosso G. Cesarini S. Cozzi R. Santini C. Carbone P. Cazzaniga I. Lovati R. Cantoni A. Ranzani P. Barra D. Pompilio G. Dimori S. Cernesi S. Riccò C. Piazzolla F. Capittini E. Rota C. Gottardi F. Merla L. Barelli A. Millul A. De G. Morrone G. Bigolari M. Minaglia C. Macchi M. Zambon F. D’Amico F. D’Amico F. Pizzorni C. DiCasaleto G. Menculini G. Marcacci M. Catanese G. Sprini D. DiCasalet T. Bocci M. Borga S. Caironi P. Cat C. Cingolani E. Avalli L. Greco G. Citerio G. Gandini L. Cornara G. Lerda R. Brazzi L. Simeone F. Caciorgna M. Alampi D. Francesconi S. Beck E. Antonini B. Vettoretto K. Meggiolaro M. Garofalo E. Bruni A. Notaro S. Varutti R. Bassi F. Mistraletti G. Marino A. Rona R. Rondelli E. Riva I. Cortegiani A. Pistidda L. D’Andrea R. Querci L. Gnesin P. Todeschini M. Lugano M. Castelli G. Ortolani M. Cotoia A. Maggiore S. DiTizio L. Graziani R. Testa I. Ferretti E. Castioni C. Lombardi F. Caserta R. Pasqua M. Simoncini S. Baccarini F. Rispoli M. Grossi F. Cancelliere L. Carnelli M. Puccini F. Biancofiore G. Siniscalchi A. Laici C. Mossello E. Torrini M. Pasetti G. Palmese S. Oggioni R. Mangani V. Pini S. Martelli M. Rigo E. Zuccalà F. Cherri A. Spina R. Calamai I. Petrucci N. Caicedo A. Ferri F. Gritti P. Brienza N. Fonnesu R. Dessena M. Fullin G. Saggioro D. on behalf of the Italian Study Group on Delirium Prevalence and features of delirium in older patients admitted to rehabilitation facilities: A multicenter study. Aging Clin. Exp. Res. 2022 34 8 1827 1835 10.1007/s40520‑022‑02099‑8 35396698
    [Google Scholar]
  52. Kim D.H. Lee S.B. Park C.M. Levin R. Metzger E. Bateman B.T. Ely E.W. Pandharipande P.P. Pisani M.A. Jones R.N. Marcantonio E.R. Inouye S.K. Comparative safety analysis of oral antipsychotics for in-hospital adverse clinical events in older adults after major surgery. Ann. Intern. Med. 2023 176 9 1153 1162 10.7326/M22‑3021 37665998
    [Google Scholar]
  53. Heimberger A.B. Lukas R.V. The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors. J. Clin. Invest. 2023 133 2 e164577 10.1172/JCI164577 36647830
    [Google Scholar]
  54. Glass O.M. Hermida A.P. Hershenberg R. Considerations and current trends in the management of the geriatric patient on a consultation-liaison service. Curr. Psychiatry Rep. 2025 202013225 1007 11920 020 10.1007/s11920‑020‑01147‑2 32285305
    [Google Scholar]
  55. Li T. Li J. Yuan L. Wu J. Jiang C. Daniels J. Mehta R.L. Wang M. Yeung J. Jackson T. Melody T. Jin S. Yao Y. Wu J. Chen J. Smith F.G. Lian Q. Lin H. Ma J. Shangguan W. Zhang X. Wang Y. Xie Z. He L. Lin W. Xiang Y. Wang J. Kong L. Zhang T. Wang Y. Bao N. Xu X. Cheng H. Lei L. Zhang Z. Fan L. Wu Y. Wei J. Shi Z. Mei W. Luo F. Zhao L. Zhang Q. Chen S. Shi X. Liang Y. Xu J. Zhou W. Zheng J. Yuan W. Lin Y. RAGA Study Investigators Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery. JAMA 2022 327 1 50 58 10.1001/jama.2021.22647 34928310
    [Google Scholar]
  56. Kassie G.M. Roughead E.E. Nguyen T.A. Pratt N.L. Kalisch Ellett L.M. The risk of preoperative central nervous system-acting medications on delirium following hip or knee surgery: A matched case-control study. Drug Saf. 2022 45 1 75 82 10.1007/s40264‑021‑01136‑1 34748199
    [Google Scholar]
  57. Austin CA Yi J Lin FC Pandharipande P Ely EW Busby-Whitehead J Carson SS The Association of Selective serotonin reuptake inhibitors with delirium in critically ill adults: A secondary analysis of the bringing to light the risk factors and incidence of neuropsychologic dysfunction in ICU survivors ICU study. Crit Care Explor 2022 19 0740 10.1097/CCE.0000000000000740
    [Google Scholar]
  58. Gray S.L. Hanlon J.T. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther. Adv. Drug Saf. 2016 7 5 217 224 10.1177/2042098616658399 27695623
    [Google Scholar]
  59. Grohmann R. Rüther E. Engel R. Hippius H. Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry 1999 32 1 21 29 10.1055/s‑2007‑979184 10071179
    [Google Scholar]
  60. Friedrich M.E. Grohmann R. Rabl U. Winkler D. Konstantinidis A. Engel R. Seifert J. Toto S. Stübner S. Frey R. Kasper S. Incidence of drug-induced delirium during treatment with antidepressants or antipsychotics: a drug surveillance report of german-speaking countries between 1993 and 2016. Int. J. Neuropsychopharmacol. 2022 25 7 556 566 10.1093/ijnp/pyac005 35106566
    [Google Scholar]
  61. Hill L. Lee K.C. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: Focus on antidepressants and antipsychotics. Ann. Pharmacother. 2013 47 1 75 89 10.1345/aph.1R343 23341158
    [Google Scholar]
  62. Karki S.D. Masood G.R. Combination risperidone and SSRI-induced serotonin syndrome. Ann. Pharmacother. 2003 37 3 388 391 10.1345/aph.1C228 12639169
    [Google Scholar]
  63. Austin C.A. Bazemore I. Yi J. Glier S. Carson S.S. The association of selective serotonin reuptake inhibitors with delirium in post-operative adults: A secondary analysis of a post-operative dataset with daily severity of illness adjustment. Delirium Commun. 2024 2024 10.56392/001c.94253 39429913
    [Google Scholar]
  64. Elsamadicy A.A. Adogwa O. Lydon E. Sergesketter A. Kaakati R. Mehta A.I. Vasquez R.A. Cheng J. Bagley C.A. Karikari I.O. Depression as an independent predictor of postoperative delirium in spine deformity patients undergoing elective spine surgery. J. Neurosurg. Spine 2017 27 2 209 214 10.3171/2017.4.SPINE161012 28574333
    [Google Scholar]
  65. Okuno K. Treatment of mental disorders during the acute phase of brain trauma. No Shinkei Geka 2021 49 5 994 999 10.11477/mf.1436204482 34615759
    [Google Scholar]
  66. Johnson R.J. III A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea. BMC Psychiatry 2018 18 1 85 10 10.1186/s12888‑018‑1651‑9 29614992
    [Google Scholar]
  67. Degner D. Grohmann R. Kropp S. Rüther E. Bender S. Engel R.R. Schmidt L.G. Severe adverse drug reactions of antidepressants: Results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004 37 39 45 10.1055/s‑2004‑815509 15052513
    [Google Scholar]
  68. Mathys M. Fang S. John J. Carter J. Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia. Ment. Health Clin. 2018 8 3 122 126 10.9740/mhc.2018.05.122 29955557
    [Google Scholar]
  69. Alexander J. Nillsen A. Venlafaxine-Induced Delirium. Aust. N. Z. J. Psychiatry 2011 45 7 598 10.3109/00048674.2011.567968 21434770
    [Google Scholar]
  70. del Río Casanova L. Portela Traba B. Díaz Llenderrozas F. Delirium inducido por altas dosis de venlafaxina. Rev. Neurol. 2015 60 10 475 477 10.33588/rn.6010.2014427 25952604
    [Google Scholar]
  71. Howe C. Ravasia S. Venlafaxine-Induced Delirium. Can. J. Psychiatry 2003 48 2 129 10 10.1177/070674370304800216 12655917
    [Google Scholar]
  72. van Noorden M.S. Vergouwen A.C. Koerselman G.F. [Delirium during withdrawal of venlafaxine]. Ned. Tijdschr. Geneeskd. 2002 146 26 1236 1237 12132141
    [Google Scholar]
  73. Suwała J. Machowska M. Wiela-Hojeńska A. Venlafaxine pharmacogenetics: A comprehensive review. Pharmacogenomics 2019 20 11 829 845 10.2217/pgs‑2019‑0031 31368838
    [Google Scholar]
  74. Coutens B Yrondi A Rampon C Guiard BP Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine. Psychopharmacology 2022 239 2735 10.1007/s00213‑022‑06203‑8
    [Google Scholar]
  75. Kishi T. Ikuta T. Sakuma K. Okuya M. Hatano M. Matsuda Y. Iwata N. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: A systematic review and network meta-analysis. Mol. Psychiatry 2023 28 1 402 409 10.1038/s41380‑022‑01824‑z 36253442
    [Google Scholar]
  76. Blythe D. Hackett L.P. Cardiovascular and neurological toxicity of venlafaxine. Hum. Exp. Toxicol. 1999 18 5 309 313 10.1191/096032799678840165 10372752
    [Google Scholar]
  77. Kelly C.A. Dhaun N. Laing W.J. Strachan F.E. Good A.M. Bateman D.N. Comparative toxicity of citalopram and the newer antidepressants after overdose. J. Toxicol. Clin. Toxicol. 2004 42 1 67 71 10.1081/CLT‑120028747 15083939
    [Google Scholar]
  78. Bousman C.A. Stevenson J.M. Ramsey L.B. Sangkuhl K. Hicks J.K. Strawn J.R. Singh A.B. Ruaño G. Mueller D.J. Tsermpini E.E. Brown J.T. Bell G.C. Leeder J.S. Gaedigk A. Scott S.A. Klein T.E. Caudle K.E. Bishop J.R. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin. Pharmacol. Ther. 2023 114 1 51 68 10.1002/cpt.2903 37032427
    [Google Scholar]
/content/journals/cn/10.2174/011570159X378277250702051515
Loading
Venlafaxine and Delirium: Understanding the Association
Bentham Science Publishers ; https://doi.org/10.2174/011570159X378277250702051515
/content/journals/cn/10.2174/011570159X378277250702051515
/content/journals/cn/10.2174/011570159X378277250702051515
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: venlafaxine ; Anticholinergic delirium ; neuropsychiatric condition ; antidepressants ; toxic delirium ; geriatric medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test